S
SCI Pharmtech Inc
TWSE:4119
SCI Pharmtech Inc
TWSE:4119
Price:
83
TWD
-0.12%
Market Closed
Market Cap:
9.9B
TWD
Balance Sheet
Balance Sheet Decomposition
SCI Pharmtech Inc
SCI Pharmtech Inc
| Current Assets | 2.1B |
| Cash & Short-Term Investments | 543.5m |
| Receivables | 869.5m |
| Other Current Assets | 723.3m |
| Non-Current Assets | 5.1B |
| Long-Term Investments | 473.2m |
| PP&E | 4.3B |
| Intangibles | 39.8m |
| Other Non-Current Assets | 302.6m |
Balance Sheet
SCI Pharmtech Inc
SCI Pharmtech Inc
Currency: TWD
Millions
Annual
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
399
|
370
|
327
|
256
|
361
|
554
|
633
|
332
|
167
|
942
|
|
| Cash |
170
|
192
|
89
|
156
|
148
|
224
|
284
|
304
|
75
|
908
|
|
| Cash Equivalents |
229
|
178
|
238
|
100
|
213
|
330
|
349
|
28
|
92
|
34
|
|
| Short-Term Investments |
169
|
432
|
538
|
415
|
430
|
466
|
0
|
360
|
98
|
89
|
|
| Total Receivables |
246
|
171
|
255
|
174
|
391
|
352
|
338
|
349
|
205
|
308
|
|
| Accounts Receivables |
237
|
168
|
249
|
174
|
389
|
352
|
338
|
83
|
174
|
307
|
|
| Other Receivables |
9
|
3
|
6
|
0
|
2
|
0
|
0
|
266
|
31
|
0
|
|
| Inventory |
510
|
554
|
498
|
483
|
503
|
527
|
381
|
294
|
513
|
530
|
|
| Other Current Assets |
0
|
9
|
5
|
12
|
22
|
37
|
567
|
62
|
60
|
85
|
|
| Total Current Assets |
1 330
|
1 536
|
1 623
|
1 339
|
1 707
|
1 936
|
1 919
|
1 397
|
1 042
|
1 953
|
|
| PP&E Net |
1 776
|
1 785
|
1 762
|
1 786
|
1 884
|
1 880
|
1 503
|
2 100
|
3 194
|
3 912
|
|
| PP&E Gross |
1 776
|
1 785
|
1 762
|
1 786
|
1 884
|
1 880
|
1 503
|
2 100
|
3 194
|
3 912
|
|
| Accumulated Depreciation |
1 157
|
1 263
|
1 350
|
1 416
|
1 522
|
1 584
|
695
|
638
|
707
|
839
|
|
| Intangible Assets |
0
|
0
|
0
|
1
|
47
|
48
|
41
|
60
|
55
|
46
|
|
| Long-Term Investments |
50
|
42
|
42
|
42
|
75
|
137
|
754
|
125
|
436
|
470
|
|
| Other Long-Term Assets |
65
|
93
|
123
|
127
|
75
|
80
|
353
|
507
|
233
|
310
|
|
| Total Assets |
3 221
N/A
|
3 457
+7%
|
3 550
+3%
|
3 296
-7%
|
3 789
+15%
|
4 081
+8%
|
4 570
+12%
|
4 190
-8%
|
4 961
+18%
|
6 691
+35%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
80
|
67
|
58
|
35
|
89
|
94
|
81
|
34
|
49
|
44
|
|
| Accrued Liabilities |
92
|
108
|
117
|
75
|
132
|
153
|
119
|
78
|
85
|
82
|
|
| Short-Term Debt |
50
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
112
|
175
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
2
|
1
|
22
|
|
| Other Current Liabilities |
175
|
498
|
280
|
233
|
336
|
335
|
921
|
635
|
524
|
247
|
|
| Total Current Liabilities |
397
|
673
|
455
|
343
|
557
|
584
|
1 122
|
748
|
770
|
570
|
|
| Long-Term Debt |
577
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
433
|
846
|
|
| Deferred Income Tax |
1
|
0
|
1
|
1
|
0
|
0
|
104
|
104
|
104
|
146
|
|
| Other Liabilities |
21
|
22
|
23
|
22
|
22
|
21
|
20
|
17
|
25
|
29
|
|
| Total Liabilities |
995
N/A
|
695
-30%
|
479
-31%
|
366
-24%
|
579
+58%
|
607
+5%
|
1 248
+106%
|
869
-30%
|
1 331
+53%
|
1 591
+19%
|
|
| Equity | |||||||||||
| Common Stock |
697
|
762
|
795
|
795
|
795
|
795
|
795
|
954
|
954
|
1 195
|
|
| Retained Earnings |
682
|
825
|
937
|
794
|
1 072
|
1 309
|
1 208
|
1 067
|
1 373
|
1 646
|
|
| Additional Paid In Capital |
858
|
1 186
|
1 348
|
1 348
|
1 348
|
1 348
|
1 348
|
1 348
|
1 357
|
2 234
|
|
| Unrealized Security Profit/Loss |
0
|
8
|
8
|
8
|
5
|
22
|
29
|
49
|
55
|
25
|
|
| Other Equity |
0
|
4
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
2 226
N/A
|
2 762
+24%
|
3 071
+11%
|
2 930
-5%
|
3 210
+10%
|
3 475
+8%
|
3 322
-4%
|
3 321
0%
|
3 629
+9%
|
5 100
+41%
|
|
| Total Liabilities & Equity |
3 221
N/A
|
3 457
+7%
|
3 550
+3%
|
3 296
-7%
|
3 789
+15%
|
4 081
+8%
|
4 570
+12%
|
4 190
-8%
|
4 961
+18%
|
6 691
+35%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
70
|
76
|
95
|
95
|
95
|
95
|
109
|
109
|
109
|
120
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
